CytoDyn (CYDY) Preferred Dividend Payments (2010 - 2013)
CytoDyn (CYDY) posted Preferred Dividend Payments of -$790.0 for Q1 2013, up 43.57% on a QoQ basis from -$1400.0 in Q3 2012, and up 98.83% year-over-year from -$397.33 in Q1 2012.
CytoDyn (CYDY) Preferred Dividend Payments (2010 - 2013) Analysis & Trends
CytoDyn's Preferred Dividend Payments history runs 4 years deep, the most recent figure standing at -$790.0 for Q1 2013.
- Quarterly Preferred Dividend Payments rose 98.83% year-over-year to -$790.0 in Q1 2013, while the trailing twelve-month figure through May 2013 was -$2190.0 (up 97.68% YoY) and the FY2013 annual result came in at -$2190.0, up 97.53% from the prior year.
- Preferred Dividend Payments was -$790.0 for Q1 2013 at CytoDyn, up from -$1400.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at -$790.0 in Q1 2013 and bottomed at -$67293.0 in Q1 2012.
- A 4-year average of -$16580.5 and a median of -$4275.0 in 2010 frame the typical range for Preferred Dividend Payments.
- Annual changes were most pronounced in 2012 — Preferred Dividend Payments plunged 1060.22% — and 2013, when it surged 98.83%.
- CytoDyn's Preferred Dividend Payments stood at -$2750.0 in 2010, then slumped by 110.91% to -$5800.0 in 2011, then soared by 75.86% to -$1400.0 in 2012, then surged by 43.57% to -$790.0 in 2013.
- Business Quant data shows CYDY's Preferred Dividend Payments at -$790.0 in Q1 2013, -$1400.0 in Q3 2012, and -$21450.0 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | CytoDyn | 248.66 Mn | 248.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2013 | -790.00 |
| Aug 31, 2012 | -1,400.00 |
| May 31, 2012 | -21,450.00 |
| Feb 29, 2012 | -67,293.00 |
| Feb 28, 2011 | -5,800.00 |
| Nov 30, 2010 | -2,750.00 |